Innovative hearings continue regarding presentations of scientific data regarding alleged toxins.  The newest example is this week...

I’m an optimist about science and the future. But some people are not so optimist, or at least focus on negative possibilities. An open...

New thinking, new technology and innovation offer interesting new possibilities for manufacturers seeking to avoid potential health risks...

It feels as if courts are running out of patience or tolerance for litigants who 1) are repeat players in the litigation industry, and 2)...

Defendants in lead cases in California took a notable hit last year when an intermediate appellate panel affirmed the trial court ruling....

More or less buying and selling legal services continues to expand, at least outside the US.  Yet another example of this aspect of the...

A new post at the ToxicoGenomica blog provides some insights into how  CRISPR cameras will – over time – reshape toxic tort litigation....

Last week’s “Facebook” discovery ruling by the New York Court of Appeals has provided some headlines.  A cogent synopsis/analysis is...

2017 was quite the year for attacks on and perceptions of “leading” public figures and institutions. In view of the new indictments by...

SCOTUSblog includes a February 16, 2018 announcement of two interesting events as to predicting outcomes at SCOTUS. The entry is pasted...

Biomarkers are changing many aspects of science and litigation. The field is still young, but promising. The point is exemplified by...

Amazing what shows up in the news everyday. One is a Valentine’s Day 2018 lawyer ad/article kind of thing promoting return to the US of...

An upcoming workshop looks interesting as to class action and “tort reform” topics. The agenda is online here, and pasted below.  A hat...

After an alleged or actual mass tort, some companies move voluntarily into chapter 11 proceedings to cope with the claims. However, some...

Continuing this week’s posts on the scale and scope of the litigation industry, it is interesting to see some of the tech titans starting...

To continue with a theme regarding the scale of mass tort litigation, this post touches on  the scale of what one can call “securities...

The scale of asbestos personal injury litigation provides another example of the scale of the mass tort litigation industry. One could...

The scale of mass tort litigation is sometimes missed. The scale of “mesh MDL litigation” is nicely captured in a February 5, 2018 post...

ToxicoGenomica is the doing business name for a collaboration between me and scientists at ArrayXpress and Innovative Science Solutions....

AI already is producing changes in law, and will produce much more. A conference at the end of this week will provide great insights....